Header Logo

Connection

Douglas Thornton to Humans

Back to Details
This is a "connection" page, showing publications Douglas Thornton has written about Humans.
Douglas Thornton
Connection Strength
1.345
Humans
  1. Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220.
    View in: PubMed
    Score: 0.094
  2. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233.
    View in: PubMed
    Score: 0.088
  3. Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185.
    View in: PubMed
    Score: 0.087
  4. Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder. Subst Use Misuse. 2023; 58(10):1187-1195.
    View in: PubMed
    Score: 0.085
  5. Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey. Int J Drug Policy. 2023 06; 116:104045.
    View in: PubMed
    Score: 0.084
  6. Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study. BMC Public Health. 2023 04 21; 23(1):728.
    View in: PubMed
    Score: 0.084
  7. Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104.
    View in: PubMed
    Score: 0.081
  8. Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior. Subst Use Misuse. 2022; 57(12):1761-1771.
    View in: PubMed
    Score: 0.080
  9. Do nursing and pharmacy students practice what they preach on safe drug storage and disposal? A cross-sectional study. Nurse Educ Today. 2021 Dec; 107:105143.
    View in: PubMed
    Score: 0.075
  10. Does Social Desirability Influence Preceptors' Completion of Student Experiential Evaluations? Am J Pharm Educ. 2020 09; 84(9):ajpe7949.
    View in: PubMed
    Score: 0.070
  11. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis. 2020 10; 99:373.
    View in: PubMed
    Score: 0.070
  12. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach. Int J Drug Policy. 2020 09; 83:102827.
    View in: PubMed
    Score: 0.069
  13. Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorder. J Subst Abuse Treat. 2020 10; 117:108073.
    View in: PubMed
    Score: 0.069
  14. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008.
    View in: PubMed
    Score: 0.069
  15. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
    View in: PubMed
    Score: 0.023
  16. Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525.
    View in: PubMed
    Score: 0.023
  17. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
    View in: PubMed
    Score: 0.022
  18. Regional Variation in Opioid-Related Emergency Medical Services Transfers During the COVID-19 Pandemic: An Interrupted Time Series Analysis. Subst Use Addctn J. 2024 Jan; 45(1):74-80.
    View in: PubMed
    Score: 0.022
  19. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655.
    View in: PubMed
    Score: 0.021
  20. Identifying predictors of generalized anxiety among student pharmacists in response to the COVID-19 pandemic. Curr Pharm Teach Learn. 2023 01; 15(1):34-42.
    View in: PubMed
    Score: 0.021
  21. Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2023 Jul; 169(1):176-184.
    View in: PubMed
    Score: 0.021
  22. Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450.
    View in: PubMed
    Score: 0.018
  23. Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 Dec 10; 10(1):21698.
    View in: PubMed
    Score: 0.018
  24. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
    View in: PubMed
    Score: 0.017
  25. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 Oct; 25(10):e1574-e1582.
    View in: PubMed
    Score: 0.017
  26. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.